Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform

Introduction: Patients with advanced-stage non-small cell lung cancer (NSCLC) may benefit from a short time-to-treatment (TTT). Predictive biomarker testing is performed prior to treatment, as recommended by various international expert consensus bodies. Genetic testing is more time-intensive than i...

Descripción completa

Detalles Bibliográficos
Autores principales: Banyi, Norbert, Alex, Deepu, Hughesman, Curtis, McNeil, Kelly, N. Ionescu, Diana, Ma, Carmen, Yip, Stephen, Melosky, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600153/
https://www.ncbi.nlm.nih.gov/pubmed/36290901
http://dx.doi.org/10.3390/curroncol29100624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600153/
https://www.ncbi.nlm.nih.gov/pubmed/36290901
http://dx.doi.org/10.3390/curroncol29100624

Ejemplares similares